Caption Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 517 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 535 |
|
|
2024
Q4 | – | Sell |
-8,405
| Closed | -$2.31M | – | 530 |
|
|
2024
Q3 | $2.31M | Sell |
8,405
-162,145
| -95% | -$44.6M | 0.04% | 84 |
|
|
2024
Q2 | $41.4M | Buy |
170,550
+56,428
| +49% | +$13.7M | 0.64% | 5 |
|
|
2024
Q1 | $17.1M | Buy |
114,122
+92,580
| +430% | +$13.8M | 0.26% | 10 |
|
|
2023
Q4 | $4.12M | Sell |
21,542
-15,958
| -43% | -$3.05M | 0.06% | 41 |
|
|
2023
Q3 | $6.64M | Buy |
+37,500
| New | +$6.64M | 0.1% | 21 |
|
|
2023
Q2 | – | Sell |
-3,000
| Closed | -$601K | – | 364 |
|
|
2023
Q1 | $601K | Buy |
3,000
+108
| +4% | +$21.6K | 0.01% | 164 |
|
|
2022
Q4 | $687K | Buy |
2,892
+1,892
| +189% | +$450K | 0.01% | 180 |
|
|
2022
Q3 | $199K | Sell |
1,000
-30,500
| -97% | -$6.07M | ﹤0.01% | 337 |
|
|
2022
Q2 | $4.59M | Buy |
+31,500
| New | +$4.59M | 0.06% | 49 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 524 |
|
|
2021
Q4 | – | Sell |
-7,800
| Closed | -$1.47M | – | 563 |
|
|
2021
Q3 | $1.47M | Buy |
7,800
+1,200
| +18% | +$227K | 0.02% | 210 |
|
|
2021
Q2 | $1.12M | Buy |
+6,600
| New | +$1.12M | 0.01% | 175 |
|
|
2021
Q1 | – | Sell |
-27,000
| Closed | -$3.51M | – | 368 |
|
|
2020
Q4 | $3.51M | Buy |
+27,000
| New | +$3.51M | 0.08% | 45 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 348 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 264 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 241 |
|
|
2018
Q4 | – | Sell |
-17,500
| Closed | -$1.53M | – | 201 |
|
|
2018
Q3 | $1.53M | Buy |
+17,500
| New | +$1.53M | 0.08% | 64 |
|